In early April 2009, the FDA handed down warning letters to 14 pharmaceutical companies for their use of paid search advertisements in the major search engines. There were three reasons for the warning letters, with the most significant being the lack of safety information describing the risks of the drugs. Paid search advertisements have a very limited number of characters available and the safety information for drugs are much too long for the medium. Read Full Entry
Categories
Trending Topics
iPad
bloggers
epatient
Innovation
pharma social media
mHealth11
mhealth
healthcare marketing
texting
SxSW
Groundswell
social network
Mobile
Social Media
Tech2011
pharma marketing
Digital Pharma East
Twitter
paid search
trend
CES
social
augmented reality
healthcare
Video
Facebook
research
pharma
digital divide
geolocation
Search
YouTube
health
iPhone
FDA
Google
ePatient 2010
DTC
#ePatCon
next gen pharma
organic search
convergence
statistics
Cisco
tablet
